Pacific Biosciences' DNA Sequencing Technology Yields New Insights into Virulence and Evolution of German E. coli Pathogen

MENLO PARK, Calif.--(BUSINESS WIRE)--An international team of scientists has successfully employed single molecule, real-time (SMRT™) DNA sequencing technology from Pacific Biosciences of California, Inc. (NASDAQ:PACB) to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak. Published online today in the New England Journal of Medicine, the results provide the most detailed genetic profile to date of the outbreak strain, including medically relevant information.

Back to news